{"name":"Avalyn Pharma Inc.","slug":"avalyn-pharma-inc","ticker":"","exchange":"","domain":"avalynpharma.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"AP01","genericName":"AP01","slug":"ap01","indication":"Other","status":"phase_2"},{"name":"AP02","genericName":"AP02","slug":"ap02","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"AP01","genericName":"AP01","slug":"ap01","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AP02","genericName":"AP02","slug":"ap02","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxNRk5Ia05rR1JGLTlIb01tMVFHWnMwelBrMTA2a19ZdnNxZzlPYkZJM05pQThQcnhRLUlPbmtiZlNsbU9wd2JkUGVCaGJMalB3YTllVG5SeFMzUTJtTmt0Q0hOY0lWRHBNY0NZeHBxUEZXWk1uWkd4cm5BMEI4ZTd0VEZmZ1NRaURYaUsxVGJfcjVjWndnOFNobmlKQ0g3ci1ESFJoWHhXZWtLbDVZRlNCNXdlN1dGQ0ppNUlLa1VweGhNMEFJdUtvb21mR05faVlVTFNVZWtHUmRrcHB2bW5uT0VyWkxXWHdRdGxNY0xYZnI2VjZhTWFj?oc=5","date":"2026-04-06","type":"pipeline","source":"GlobeNewswire","summary":"Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors - GlobeNewswire","headline":"Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wJBVV95cUxQWmhtTjVaUEh0dl9JcGlpWmxwcWpJaDJLU3BhY0gyR3V0RW5nbUlvV1kzVENjRnRuVDg1eHJmOW1aNzNVV283NDhacGw0ZFZmSjdmRW4za0xpclRsTE9iUVo5UGZmMnpjUEs5VnVGbGt3blpTdTNyajNHZzB2dlBIUU5CWDI4YXJ6a2MzQUptU0Q0OUZKRXNneW91bmg3TlB0T0NRYnJzWm5WNjVhblpJZlUxZkZ3MDlXTkxVc3dFMldXNUJYWjkzbmFDcEEzMmlVZnFwUm1mOHRhbWgtcmtIVjlubU1ETXJUekNIOUtraV9DV2xtUk4xcm1XUHFyclFkSVFaX3cxRlQxa052dGdwNE5UWGVEWVJldmZSR0g0TUVvN1lPdFlZd2lTU3IxNmluX1FUNGNnQ1V4SXFOd0szRHZndlgtMW5VcjAwQ1cyMURnMF9Hc3BGYVFwVm9YZ1k?oc=5","date":"2026-03-25","type":"pipeline","source":"GlobeNewswire","summary":"Avalyn Announces Publication Demonstrating Correlation Between Imaging, Improved Lung Function, and Quality of Life with AP01 in Patients with Idiopathic Pulmonary Fibrosis - GlobeNewswire","headline":"Avalyn Announces Publication Demonstrating Correlation Between Imaging, Improved Lung Function, and Quality of Life with","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAJBVV95cUxOSVVoR2NucDU4RnVJTGEtaEUyekhpMm1jRHNESm9FemxTUG5HWHM4c2Z4Sm8tblZoWnQtdHpmSERCYkVqVFNBc2NSQXZJM1pBYThHWENuSXZtQmhsazBUVWljZ2FGZGhqQmN3QjRQcjBNOFdTT2dlV1h3TWdjRTJSZzd6aFJmU1dsaElHTjVCV3Nha3F6eG5iRENEaHRBcG00RUc4NWUtNF9qN1phczhrR0tobGVKUkpUU3FKTzF5cGdRMHB2bkpGcTZaWkU1UHNrUDZKVzRjQ0s4cXV5Mk9UVFRhMksybHcyRjNZcFJxQzk0cFBESTlkdVdqVnVNeFFwTkR6ZElKMGw3WVdEV01LM1gybktwZkUwM3l0SGxvSDlJRXNiTFV0enQ3cmFoaXlFNUNQWHZLVWtNMzhpWDlOa3JGYmtGU1VQ?oc=5","date":"2026-03-23","type":"trial","source":"GlobeNewswire","summary":"Avalyn Announces First Patient Dosed in AURA Phase 2 - GlobeNewswire","headline":"Avalyn Announces First Patient Dosed in AURA Phase 2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQcTkxeXNwTXMxWFljZXNaY3BkNFhjLWZ6MFgtUEtEVm1zWU9UbHFtSGFEX0swQ0pUVS1xV29ULWNsdGdxUG5LNnV2N1I1MmZXSVdHUnNiVGMyN3ozZzBVcEFBQXpkeF9PWHJ3UUNBS21qdjZFcG44eW1GLU9RVnVUbFpVYndNWVZ3aEEzMXNwNFFjTHRoQnN1TW1xLTJORF8xT0p3X0QzSDd5RzVacUNvNG9aQVFsNFNYTmlhWFhLZ25rQQ?oc=5","date":"2026-03-06","type":"pipeline","source":"BioCentury","summary":"A pulmonary fibrosis proof-of-concept wave puts antifibrotic progress within reach - BioCentury","headline":"A pulmonary fibrosis proof-of-concept wave puts antifibrotic progress within reach","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxQblNYMFc0dU13dU5CcVBtVk1CWG5EMU5fSks0SmxCQ1QyejZkRnRMYXdpdGNZQXNjb3c3QTdEYTRpS0h5Qk5aSkNKUWw4Zzg5bl80ZndIaW1PWjBMbDVNWXdNcGNfRXI1R01UU0tUTTdPNnFEOVYyMmltMk5EanNnRlZITlFweTVnVkpkZ1NoMEdYMVJZZU9tX1FLSDlNMFhZT1dHQ29QTkZaUzI4R0VOazA1SFQza3gxdll2c3llOVdqTXU2UkU3MXdKMjdqNldZcF92SVBmbUV3VkJzMkdybVJrNnNQLUZTUURhZi1R?oc=5","date":"2026-03-05","type":"pipeline","source":"GlobeNewswire","summary":"Avalyn Appoints Biopharmaceutical Industry Leader Kate Haviland to Board of Directors - GlobeNewswire","headline":"Avalyn Appoints Biopharmaceutical Industry Leader Kate Haviland to Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPc2g0ZEFBWHJjdHRhZDJGNXprYTFSSXJ4bDVoeVRMV1lDc1c2ZDAxUVNuZmFKd2NQU3JveWpSTy1YNVgtMVJzY2xUOFlLb21SZENsVC1LT194cHdlLUlfQ2JrM0cyNzEwZ2ctLVlyRnRxM3dlMlRRdkpPZTRPY1VHNVI5M3d1dncyNmltajdHU2VWTEpYaVpsbFM1TW1wTEZCanpKeA?oc=5","date":"2025-07-23","type":"pipeline","source":"BioWorld News","summary":"Avalyn secures $100M for inhaled pulmonary fibrosis candidates - BioWorld News","headline":"Avalyn secures $100M for inhaled pulmonary fibrosis candidates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQV3FTUDYzV0JObXc0WWpNbkxRREtTSVBGT1c5ai1VTk9oTE5GQ25aVTY3SnRZUUNRdkEwbkJrV0pjYVZ4bGZ5V2FaelNsTHJKMlRfaThGRWpJY09Hc3hTM0tyVjd6YUc2X3Z5X3dpRFpOaGxtX08yaFZoN3dFTnBoTUx5dWpGRFh5NHFVNGd5VzhUWGxpLXNrdVZjTV9VOFJ4Zm11bFFR?oc=5","date":"2025-07-22","type":"pipeline","source":"BioSpace","summary":"Avalyn Pharma Adds $100M Series D for Inhaled Pulmonary Fibrosis Drugs - BioSpace","headline":"Avalyn Pharma Adds $100M Series D for Inhaled Pulmonary Fibrosis Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNeTd6cG9TeWtuQ0YyZ2NyUDhzVk9qTko5WlRDM3psNWtpRlJrNnhmTnhRNkh2N21aR1M4X3lPUVNJNUE3dFpFZGJCMkMzZlU1cXBWb1IzTmJvcEZVSkYyTlU0SDRxNFhGaG9GUVE4SVN2QnZFeXZzRUpNbTJUZzNIUTZEbEZPdENXZzM3MG9GRDNhdHJBREo4N21VOVFPSFdmWGh1cmJLcFpqNGJMbkRJRGR3bkY0RHQ5em1vYzdfUkpMZw?oc=5","date":"2025-07-22","type":"pipeline","source":"wsgr.com","summary":"Firm Advises SR One, Novo Holdings on Avalyn’s $100 Million Oversubscribed Series D - wsgr.com","headline":"Firm Advises SR One, Novo Holdings on Avalyn’s $100 Million Oversubscribed Series D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPWS1QRXREa3dEeW1YeFJwdkJHaDNZQTItNmNudVNlOWEwZmExOGlEMjN4d0ZpYUJtX0lkaTJLb0htYmRyYmFWLTBWQ2JLUTFhRC1Cd29scnJkM2pOZTBSQWVqRHhqLVF1Ymdpc2czem03dDEzeDVzeU5Sem5jWGV6S1locTQ?oc=5","date":"2025-07-22","type":"pipeline","source":"The Business Journals","summary":"Cambridge lung disease biotech raises $100M, and other life sciences news - The Business Journals","headline":"Cambridge lung disease biotech raises $100M, and other life sciences news","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxPWXp4VHpLWlpSc2U0UjloaEJtWUR1VFRYSW8xWHdWemd6cTVYbFk1Mk0zSDhDblVWdlpvU29leGVmazhxQkNGQkp1QjQzZllCYlNUS2hWQWszM2R5Q0JuOTdLaS1WOG1fOWFLNjRCQXpRX18yOFE4Wi1Eb3phQS1yRGhpUy1Jd3lNcGpCWnBJQWJFeHZla1U2bld5RTc0ZUtIYzdlbC1IOGw1R3ZRME45X1p2bFYxYzdNb0R6T3ZOLXF5QlV4cU45cWVxb2ZBT0U1NUd2Zzh3TXdkZXpMT0laMWdxNVBaVlBhMk52Z252ZWN5RUlzMDNZWnJITWFoazA1dVh0RlZFTUl3SDdyZnBuZVkyM3hkMkdSa3lRb19udlROOFRWNUw5LTVtUjZhR0ZiYy1RYkl0SjMzYV9vMHdVNWFtb0g0d0E?oc=5","date":"2025-07-22","type":"pipeline","source":"GlobeNewswire","summary":"Avalyn Completes Oversubscribed $100 Million Series D - GlobeNewswire","headline":"Avalyn Completes Oversubscribed $100 Million Series D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPZFV5cmRKNzBhSzhjcHJMczZqVDNnc3Q3U0N2elFEblI5QUsxdF9fSW9EWmxmUWNFcTdlbEpIdFBkYy01RDBzbFRoOEhJQ1htNl9maGJOc2E4bXUwdDZaVDZpT1lnQnhydmRqdVRFNmZNM1FfSGgxclE5UWhzcl9aREQ5QQ?oc=5","date":"2024-10-08","type":"pipeline","source":"Yahoo Finance","summary":"Avalyn CEO Lyn Baranowski Named a PharmaVoice 100 Honoree - Yahoo Finance","headline":"Avalyn CEO Lyn Baranowski Named a PharmaVoice 100 Honoree","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNX21TYXkwVmJOSG9LSlFaOWtlMUFPYlFnOHZXMlZCWEFpWnNubVU5TVE0clhEa3YzYmRWUTlRVHNuYko2SUdSakZCU1BwZVRpZ29TMnZYTFNQT3M3UGlDQnhRQklocGRXNjVOSjM4eUhCc1RoOFphX2xXR3NTM0JSbFE1c0FPTXRnQXNkdWM2YzBRZHpWZDAwb1ZKWG81ci1Pdjd5YnhyT1RsZ21VRHVCbWJWZGkyOVVWY2c?oc=5","date":"2022-10-17","type":"pipeline","source":"businesswire.com","summary":"Avalyn Pharma Appoints Lyn Baranowski Chief Executive Officer - businesswire.com","headline":"Avalyn Pharma Appoints Lyn Baranowski Chief Executive Officer","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}